In recent years MBS has significantly increased its R&D facilities and assembled a dedicated team of R&D scientists whose only focus is to expand the antibody product line and add innovation to our custom services.

Click Here to See What’s New from MBS R&D

Collaboration Opportunities:

• Leverage 20+ years of premier Hybridoma Development Experience at MBS with your expertise in the target of shared market interest

• Generate a fair and mutually beneficial licensing agreement of the monoclonal antibody

• Gain access to (or leverage) MBS network of contacts in biotechnology and diagnostic industries to sell antibody and generate revenue for your institution

• Areas of collaborative interest
  • Infectious Disease
  • Veterinary Targets
  • Biomarkers
  • Food / Water Safety
  • Drug Development
  • Other

Contact Technical Marketing Analyst or Fill out our Application for Collaboration.